{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T10:55:29Z","timestamp":1772708129772,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T00:00:00Z","timestamp":1587772800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T00:00:00Z","timestamp":1587772800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370689"],"award-info":[{"award-number":["81370689"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81571404"],"award-info":[{"award-number":["81571404"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Shanghai Science and Technology","award":["16411950500"],"award-info":[{"award-number":["16411950500"]}]},{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81502240"],"award-info":[{"award-number":["81502240"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>Currently, the function and mechanisms of long non-coding RNAs (lncRNAs) involved in the metastasis of epithelial ovarian cancer (EOC), especially those of the lncRNAs participated in the epithelial-mesenchymal transition (EMT) process, remains largely unknown. Here, we focused on a lncRNA named AOC4P and analysed its role in EOC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>The expression of AOC4P gene was examined with quantitative real-time quantitative PCR (qRT-PCR). The cell migration and invasion were detected by Transwell and scratch assays. The in vivo metastatic activity was evaluated by intraperitoneal metastasis model. The downstream genes were investigated by a tumour EMT real-time polymerase chain reaction (RT-PCR) array, and validated by qRT-PCR and Western blot.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The results showed that AOC4P expression levels were decreased in EOC tissues and cell lines, and that the under-expression of AOC4P was positively correlated with FIGO stage and lymph node metastasis. Furthermore, the knockdown of AOC4P expression in poorly metastatic EOC cell lines remarkably facilitated cell migration\/invasion while the overexpression of AOC4P in highly metastatic EOC cell lines reduced the metastatic ability of these cells in vitro. Consistently, the anti-metastatic role of AOC4P in vivo was also verified by bioluminescence imaging and tumour dissection. Mechanistically, the anti-metastatic effect of AOC4P in EOC was partially mediated by the EMT process accompanied by the alterations in MMP9 and COL1A2 expression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These data highlight that AOC4P plays a critical role in EOC invasion\/metastasis and could function as a novel and effective target for the lncRNA-based anti-metastatic clinical management of EOC.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13048-020-00644-5","type":"journal-article","created":{"date-parts":[[2020,4,25]],"date-time":"2020-04-25T12:02:43Z","timestamp":1587816163000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Long non-coding RNA AOC4P suppresses epithelial ovarian cancer metastasis by regulating epithelial-mesenchymal transition"],"prefix":"10.1186","volume":"13","author":[{"given":"Xiaojing","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjun","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keqin","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,25]]},"reference":[{"key":"644_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.6004\/jnccn.2011.0008","volume":"9","author":"RJ Morgan Jr","year":"2011","unstructured":"Morgan RJ Jr, Alvarez RD, Armstrong DK, Boston B, Burger RA, Chen LM, et al. Epithelial ovarian cancer. J Natl Compr Canc Netw. 2011;9:82\u2013113.","journal-title":"J Natl Compr Canc Netw"},{"key":"644_CR2","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ccr.2012.12.020","volume":"23","author":"D Yang","year":"2013","unstructured":"Yang D, Sun Y, Hu L, Zheng H, Ji P, Pecot CV, et al. Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. Cancer Cell. 2013;23:186\u201399.","journal-title":"Cancer Cell"},{"key":"644_CR3","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0140-6736(10)61268-8","volume":"376","author":"GJ Rustin","year":"2010","unstructured":"Rustin GJ, van der Burg ME, Griffin CL, Guthrie D, Lamont A, Jayson GC, et al. Early versus delayed treatment of relapsed ovarian cancer (MRC OV05\/EORTC 55955): a randomised trial. Lancet. 2010;376:1155\u201363.","journal-title":"Lancet."},{"key":"644_CR4","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ccr.2013.09.007","volume":"24","author":"S Vanharanta","year":"2013","unstructured":"Vanharanta S, Massague J. Origins of metastatic traits. Cancer Cell. 2013;24:410\u201321.","journal-title":"Cancer Cell"},{"key":"644_CR5","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1038\/onc.2011.429","volume":"31","author":"L Cao","year":"2012","unstructured":"Cao L, Shao M, Schilder J, Guise T, Mohammad KS, Matei D. Tissue transglutaminase links TGF-beta, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer. Oncogene. 2012;31:2521\u201334.","journal-title":"Oncogene"},{"key":"644_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2009.09.017","volume":"291","author":"D Vergara","year":"2010","unstructured":"Vergara D, Merlot B, Lucot JP, Collinet P, Vinatier D, Fournier I, et al. Epithelial-mesenchymal transition in ovarian cancer. Cancer Lett. 2010;291:59\u201366.","journal-title":"Cancer Lett"},{"key":"644_CR7","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119:1420\u20138.","journal-title":"J Clin Invest"},{"key":"644_CR8","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1111\/j.1349-7006.2007.00550.x","volume":"98","author":"A Moustakas","year":"2007","unstructured":"Moustakas A, Heldin CH. Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci. 2007;98:1512\u201320.","journal-title":"Cancer Sci"},{"key":"644_CR9","doi-asserted-by":"publisher","first-page":"342","DOI":"10.5582\/bst.2018.01181","volume":"12","author":"X Lin","year":"2018","unstructured":"Lin X, Qiu J, Hua K. Long non-coding RNAs as emerging regulators of epithelial to mesenchymal transition in gynecologic cancers. Bioscience trends. 2018;12:342\u201353.","journal-title":"Bioscience trends"},{"key":"644_CR10","doi-asserted-by":"crossref","first-page":"23342","DOI":"10.18632\/oncotarget.4344","volume":"6","author":"TH Wang","year":"2015","unstructured":"Wang TH, Lin YS, Chen Y, Yeh CT, Huang YL, Hsieh TH, et al. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition. Oncotarget. 2015;6:23342\u201357.","journal-title":"Oncotarget."},{"key":"644_CR11","first-page":"1840","volume":"10","author":"J Kang","year":"2017","unstructured":"Kang J, Li Z, Kong FH, Zhang M, Chang H. Overexpression of lncRNA AOC4P indicates a poor prognosis for colorectal cancer and regulates cell metastasis by epithelial mesenchymal transition. Int J Clin Exp Pathol. 2017;10:1840\u20136.","journal-title":"Int J Clin Exp Pathol"},{"key":"644_CR12","doi-asserted-by":"crossref","first-page":"175628481982769","DOI":"10.1177\/1756284819827697","volume":"12","author":"K Zhang","year":"2019","unstructured":"Zhang K, Lu C, Huang X, Cui J, Li J, Gao Y, et al. Long noncoding RNA AOC4P regulates tumor cell proliferation and invasion by epithelial-mesenchymal transition in gastric cancer. Ther Adv Gastroenterol. 2019;12:1756284819827697.","journal-title":"Ther Adv Gastroenterol"},{"key":"644_CR13","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1525-1438.2006.00296.x","volume":"16","author":"F Bai","year":"2006","unstructured":"Bai F, Feng J, Cheng Y, Shi J, Yang R, Cui H. Analysis of gene expression patterns of ovarian cancer cell lines with different metastatic potentials. Int J Gynecol Cancer. 2006;16:202\u20139.","journal-title":"Int J Gynecol Cancer"},{"key":"644_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041410","volume":"7","author":"J Lehtinen","year":"2012","unstructured":"Lehtinen J, Raki M, Bergstrom KA, Uutela P, Lehtinen K, Hiltunen A, et al. Pre-targeting and direct immunotargeting of liposomal drug carriers to ovarian carcinoma. PLoS One. 2012;7:e41410.","journal-title":"PLoS One"},{"key":"644_CR15","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.ygyno.2010.08.034","volume":"119","author":"J Li","year":"2010","unstructured":"Li J, Liang S, Yu H, Zhang J, Ma D, Lu X. An inhibitory effect of miR-22 on cell migration and invasion in ovarian cancer. Gynecol Oncol. 2010;119:543\u20138.","journal-title":"Gynecol Oncol"},{"key":"644_CR16","first-page":"233","volume":"18","author":"X Shenhua","year":"1999","unstructured":"Shenhua X, Lijuan Q, Hanzhou N, Xinghao N, Chihong Z, Gu Z, et al. Establishment of a highly metastatic human ovarian cancer cell line (HO-8910PM) and its characterization. J Exp Clin Cancer Res. 1999;18:233\u20139.","journal-title":"J Exp Clin Cancer Res"},{"key":"644_CR17","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1631\/jzus.B1000192","volume":"12","author":"Y Wang","year":"2011","unstructured":"Wang Y, Dong L, Cui H, Shen DH, Wang Y, Chang XH, et al. Up-regulation of mitochondrial antioxidation signals in ovarian cancer cells with aggressive biologic behavior. J Zhejiang Univ Sci B. 2011;12:346\u201356.","journal-title":"J Zhejiang Univ Sci B"},{"key":"644_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046609","volume":"7","author":"W Xu","year":"2012","unstructured":"Xu W, Mezencev R, Kim B, Wang L, McDonald J, Sulchek T. Cell stiffness is a biomarker of the metastatic potential of ovarian cancer cells. PLoS One. 2012;7:e46609.","journal-title":"PLoS One"},{"key":"644_CR19","first-page":"891","volume":"53","author":"D Yu","year":"1993","unstructured":"Yu D, Wolf JK, Scanlon M, Price JE, Hung MC. Enhanced c-erbB-2\/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A. Cancer Res. 1993;53:891\u20138.","journal-title":"Cancer Res"},{"key":"644_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ygyno.2014.03.556","volume":"134","author":"JJ Qiu","year":"2014","unstructured":"Qiu JJ, Lin YY, Ye LC, Ding JX, Feng WW, Jin HY, et al. Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer. Gynecol Oncol. 2014;134:121\u20138.","journal-title":"Gynecol Oncol"},{"key":"644_CR21","doi-asserted-by":"crossref","unstructured":"Li T, Zhu J, Zuo S, Chen S, Ma J, Ma Y, et al. 1,25(OH)2D3 attenuates IL-1beta-induced epithelial to mesenchymal transition through inhibiting the expression of lncTCF7. Oncol Res. 2019;27:739\u201350.","DOI":"10.3727\/096504018X15360541345000"},{"key":"644_CR22","doi-asserted-by":"crossref","unstructured":"Wu B, Chen M, Gao M, Cong Y, Jiang L, Wei J, et al. Down-regulation of lncTCF7 inhibits cell migration and invasion in colorectal cancer via inhibiting TCF7 expression. Hum Cell. 2019;32:31\u201340.","DOI":"10.1007\/s13577-018-0217-y"},{"key":"644_CR23","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13046-015-0229-3","volume":"34","author":"J Wu","year":"2015","unstructured":"Wu J, Zhang J, Shen B, Yin K, Xu J, Gao W, et al. Long noncoding RNA lncTCF7, induced by IL-6\/STAT3 transactivation, promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transition. J Exp Clin Cancer Res. 2015;34:116.","journal-title":"J Exp Clin Cancer Res"},{"key":"644_CR24","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1002\/ijc.31605","volume":"143","author":"W Wu","year":"2018","unstructured":"Wu W, Chen F, Cui X, Yang L, Chen J, Zhao J, et al. LncRNA NKILA suppresses TGF-beta-induced epithelial-mesenchymal transition by blocking NF-kappaB signaling in breast cancer. Int J Cancer. 2018;143:2213\u201324.","journal-title":"Int J Cancer"},{"key":"644_CR25","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.18632\/oncotarget.13725","volume":"8","author":"S Xia","year":"2017","unstructured":"Xia S, Wang C, Ni X, Ni Z, Dong Y, Zhan W. NONHSAT076754 aids ultrasonography in predicting lymph node metastasis and promotes migration and invasion of papillary thyroid cancer cells. Oncotarget. 2017;8:2293\u2013306.","journal-title":"Oncotarget."},{"key":"644_CR26","doi-asserted-by":"crossref","first-page":"6555","DOI":"10.18632\/oncotarget.14149","volume":"8","author":"J Xiong","year":"2017","unstructured":"Xiong J, Liu Y, Luo S, Jiang L, Zeng Y, Chen Z, et al. High expression of the long non-coding RNA HEIRCC promotes renal cell carcinoma metastasis by inducing epithelial-mesenchymal transition. Oncotarget. 2017;8:6555\u201363.","journal-title":"Oncotarget."},{"key":"644_CR27","doi-asserted-by":"publisher","first-page":"11924","DOI":"10.1038\/srep11924","volume":"5","author":"J Zhuang","year":"2015","unstructured":"Zhuang J, Lu Q, Shen B, Huang X, Shen L, Zheng X, et al. TGFbeta1 secreted by cancer-associated fibroblasts induces epithelial-mesenchymal transition of bladder cancer cells through lncRNA-ZEB2NAT. Sci Rep. 2015;5:11924.","journal-title":"Sci Rep"},{"key":"644_CR28","doi-asserted-by":"crossref","first-page":"62520","DOI":"10.18632\/oncotarget.11528","volume":"7","author":"W Huang","year":"2016","unstructured":"Huang W, Cui X, Chen J, Feng Y, Song E, Li J, et al. Long non-coding RNA NKILA inhibits migration and invasion of tongue squamous cell carcinoma cells via suppressing epithelial-mesenchymal transition. Oncotarget. 2016;7:62520\u201332.","journal-title":"Oncotarget."},{"key":"644_CR29","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1158\/1055-9965.98.14.1","volume":"14","author":"A Lukanova","year":"2005","unstructured":"Lukanova A, Kaaks R. Endogenous hormones and ovarian cancer: epidemiology and current hypotheses. Cancer Epidemiol Biomarkers Prev. 2005;14:98\u2013107.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"644_CR30","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.ygyno.2012.12.018","volume":"128","author":"TK Chao","year":"2013","unstructured":"Chao TK, Yo YT, Liao YP, Wang YC, Su PH, Huang TS, et al. LIM-homeobox transcription factor 1, alpha (LMX1A) inhibits tumourigenesis, epithelial-mesenchymal transition and stem-like properties of epithelial ovarian cancer. Gynecol Oncol. 2013;128:475\u201382.","journal-title":"Gynecol Oncol"},{"key":"644_CR31","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1158\/0008-5472.CAN-10-3035","volume":"71","author":"CS Tellez","year":"2011","unstructured":"Tellez CS, Juri DE, Do K, Bernauer AM, Thomas CL, Damiani LA, et al. EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells. Cancer Res. 2011;71:3087\u201397.","journal-title":"Cancer Res"},{"key":"644_CR32","doi-asserted-by":"crossref","first-page":"101042831770912","DOI":"10.1177\/1010428317709129","volume":"39","author":"J Yu","year":"2017","unstructured":"Yu J, Han Q, Cui Y. Decreased long non-coding RNA SPRY4-IT1 contributes to ovarian cancer cell metastasis partly via affecting epithelial-mesenchymal transition. Tumour Biol. 2017;39:1010428317709129.","journal-title":"Tumour Biol"},{"key":"644_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122679","volume":"10","author":"Y Shi","year":"2015","unstructured":"Shi Y, Liu Y, Wang J, Jie D, Yun T, Li W, et al. Downregulated long noncoding RNA BANCR promotes the proliferation of colorectal Cancer cells via Downregualtion of p21 expression. PLoS One. 2015;10:e0122679.","journal-title":"PLoS One"},{"key":"644_CR34","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.biopha.2015.04.007","volume":"72","author":"L Li","year":"2015","unstructured":"Li L, Zhang L, Zhang Y, Zhou F. Increased expression of LncRNA BANCR is associated with clinical progression and poor prognosis in gastric cancer. Biomed Pharmacother. 2015;72:109\u201312.","journal-title":"Biomed Pharmacother"},{"key":"644_CR35","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/ijc.30039","volume":"139","author":"S Dhamija","year":"2016","unstructured":"Dhamija S, Diederichs S. From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis. Int J Cancer. 2016;139:269\u201380.","journal-title":"Int J Cancer"},{"key":"644_CR36","first-page":"249","volume":"8","author":"T Fujioka","year":"2001","unstructured":"Fujioka T, Takebayashi Y, Kihana T, Kusanagi Y, Hamada K, Ochi H, et al. Expression of E-cadherin and beta-catenin in primary and peritoneal metastatic ovarian carcinoma. Oncol Rep. 2001;8:249\u201355.","journal-title":"Oncol Rep"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-020-00644-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-020-00644-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-020-00644-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T08:27:11Z","timestamp":1666427231000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-020-00644-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,25]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["644"],"URL":"https:\/\/doi.org\/10.1186\/s13048-020-00644-5","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,25]]},"assertion":[{"value":"29 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of the Obstetrics and Gynecology Hospital of Fudan University (No. [2017]82) and written informed consent was obtained for the use of tissue samples from all participants enrolled in this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45"}}